The failure of anxiolytic therapies in early clinical trials: what needs to be done. [electronic resource]
- Expert opinion on investigational drugs Apr 2015
- 543-56 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-7658
10.1517/13543784.2015.1019063 doi
Animals Anti-Anxiety Agents--adverse effects Anxiety Disorders--drug therapy Clinical Trials as Topic--methods Drug Design Drug Evaluation, Preclinical--methods Humans